MILLERSBURG, PA—Thermo Fisher Scientific Inc. plans to invest $40 million to expand its medical device assembly plant here, creating more than 100 local jobs.
Thermo Fisher, a supplier of scientific instrumentation, reagents and consumables, and software services, bought the facility in 2015, and for the last two years has built out and modernized the warehouse and clean rooms.
The expansion is part of a $650 million multiyear investment announced last fall to ramp up bioprocessing production capacity for critical materials used in developing biologics and vaccines, including those for COVID-19. The project includes a new, 47,000-square-foot warehouse. Once the expansion is completed by mid-2023, more than 1,000 people will be employed at the site.
“Since the start of the pandemic, the Millersburg site has been instrumental in supporting more than 20 pharmaceutical partners developing life-saving therapies and vaccines,” says Mitch Kennedy, president of single-use technologies at Thermo Fisher Scientific. “Our expanded bioprocessing capabilities will ensure that we can continue to deliver essential supplies to our customers as demand surges.”
